T&R Biofab Co. Ltd (246710) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.002x

Based on the latest financial reports, T&R Biofab Co. Ltd (246710) has a cash flow conversion efficiency ratio of 0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩17.53 Million ≈ $11.88K USD) by net assets (₩11.31 Billion ≈ $7.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 246710 equity to assets ratio to measure how much of total assets are equity-financed.

T&R Biofab Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how T&R Biofab Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check T&R Biofab Co. Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

T&R Biofab Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of T&R Biofab Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Seresco S.A. MC:SCO	0.137x
Firetrade Engineering PCL BK:FTE	0.045x
ClimateRock Class A Ordinary Shares NASDAQ:CLRC	0.010x
Widepoint C NYSE MKT:WYY	0.488x
Shin Shin Co Ltd TW:2901	0.027x
Bluecom Co. Ltd KQ:033560	0.002x
Drb Holding KO:004840	-0.008x
Dreadnought Resources Ltd AU:DRE	-0.014x

Annual Cash Flow Conversion Efficiency for T&R Biofab Co. Ltd (2015–2024)

The table below shows the annual cash flow conversion efficiency of T&R Biofab Co. Ltd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of T&R Biofab Co. Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩24.21 Billion ≈ $16.41 Million	₩-11.73 Billion ≈ $-7.95 Million	-0.485x	-117.11%
2023-12-31	₩31.20 Billion ≈ $21.14 Million	₩-6.96 Billion ≈ $-4.72 Million	-0.223x	-48.88%
2022-12-31	₩39.26 Billion ≈ $26.61 Million	₩-5.89 Billion ≈ $-3.99 Million	-0.150x	+17.34%
2021-12-31	₩41.69 Billion ≈ $28.25 Million	₩-7.56 Billion ≈ $-5.12 Million	-0.181x	+0.27%
2020-12-31	₩46.05 Billion ≈ $31.21 Million	₩-8.38 Billion ≈ $-5.68 Million	-0.182x	+12.97%
2019-12-31	₩24.76 Billion ≈ $16.78 Million	₩-5.17 Billion ≈ $-3.51 Million	-0.209x	-11.74%
2018-12-31	₩30.27 Billion ≈ $20.51 Million	₩-5.66 Billion ≈ $-3.84 Million	-0.187x	+54.45%
2017-12-31	₩9.07 Billion ≈ $6.15 Million	₩-3.72 Billion ≈ $-2.52 Million	-0.411x	-40.25%
2016-12-31	₩8.85 Billion ≈ $6.00 Million	₩-2.59 Billion ≈ $-1.76 Million	-0.293x	+0.24%
2015-12-31	₩3.58 Billion ≈ $2.42 Million	₩-1.05 Billion ≈ $-710.94K	-0.293x	--

About T&R Biofab Co. Ltd

KQ:246710 Korea Medical Devices

Market Cap

$55.92 Million

₩82.52 Billion KRW

Market Cap Rank

#21419 Global

#1224 in Korea

Share Price

₩2705.00

Change (1 day)

-9.83%

52-Week Range

₩1194.00 - ₩4535.00

All Time High

₩44150.00